JBC Transcription and Nuclear Factor Monoclonals

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M106372200 on December 26, 2001

J. Biol. Chem., Vol. 277, Issue 11, 8906-8911, March 15, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/11/8906    most recent
M106372200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marchand, C.
Right arrow Articles by Pommier, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchand, C.
Right arrow Articles by Pommier, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Interaction of Human Nuclear Topoisomerase I with Guanosine Quartet-forming and Guanosine-rich Single-stranded DNA and RNA Oligonucleotides*

Christophe MarchandDagger , Philippe PourquierDagger , Gary S. LacoDagger , Naijie Jing§, and Yves PommierDagger

From the Dagger  Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892-4255 and § Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030

Received for publication, July 9, 2001, and in revised form, November 5, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Human nuclear DNA topoisomerase I (top1) plays a crucial role in DNA replication, transcription, and chromosome condensation. In this study, we show that intra- and intermolecular guanosine quartets (G-quartets) can inhibit top1-mediated DNA cleavage at a high affinity site. Top1-mediated DNA cleavage was also inhibited by a 16-mer single-stranded oligodeoxynucleotide (ODN) containing a G-rich sequence (G2T2G5TG2TG3) and by its RNA equivalent, neither of which form G-quartet structures. A comparison of various single-stranded ODN for their ability to inhibit top1-mediated DNA cleavage indicated that G-rich sequences containing repeats of 2 or 3 consecutive guanines interspaced with thymines specifically inhibited top1. We also found that both single-stranded and G-quartet-forming ODNs bind to top1 without being cleaved by the enzyme. These results demonstrate that either DNA or RNA G-rich single-stranded and G-quartet-forming oligonucleotides can bind to top1 and prevent cleavage of duplex DNA.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

DNA sequences containing a high percentage of guanine (G) can form four-stranded structures referred to as G-quartets or G-quadruplexes (for review see Ref. 1). Such sequences can be found in telomeric regions (2), gene promoters (3, 4), and immunoglobulin switch regions (5). G-quartet structures are made of G-stacked tetrads corresponding to the planar association of guanines in a cyclic Hoogsteen hydrogen-bonding arrangement (6, 7). Stacked tetrads are stabilized by monovalent cations such as Na+ or K+ (8). G-quartet structures have been proposed to play important roles in transcription regulation, alignment of chromosome pairs and telomerase activity. Several cellular proteins have been reported to bind to G-quartet structures (9-15). Some of these proteins, such as the beta -subunit of the Oxytricha telomere-binding protein (9) and RAP1 (repressor activator protein 1 (16)) promote G-quartet formation. Conversely, helicases such as the simian virus 40 (SV40) large T-antigen (17), the Bloom's syndrome helicase (Blm (18)), the subgenomic segment 1 helicase (Sgs1 (19)), and the Werner syndrome helicase (Wrn (20)) have been shown to unwind G-quartet structures in vitro.

Eukaryotic nuclear DNA topoisomerase I (top1)1 is an ubiquitous and multifunctional enzyme that regulates DNA topology during transcription, replication, chromosome condensation, and possibly recombination (for review see Refs. 21 and 22) by reversibly cleaving one strand of duplex DNA and relaxing DNA supercoiling. For the cleavage reaction, top1 forms a covalent 3'-phosphotyrosyl bond between a tyrosine residue (Tyr-723 for human top1) and the 3'-end of the broken DNA strand while leaving a 5'-hydroxyl terminus at the other end of the cleaved DNA (23). Under normal conditions, the cleavage complexes are rapidly reversible after relaxation of DNA supercoiling (intramolecular reactions) and eventually DNA recombination (intermolecular reactions). Top1 inhibitors, such as camptothecin and its derivatives, selectively inhibit eukaryotic top1 by reversibly preventing the religation step of the enzyme-mediated DNA nicking-closing reaction (24, 25). Dissociation of the DNA strand 3' from the cleavage site, due to the presence of a nick, gap, or single-stranded branch in the vicinity, prevents the religation step of top1 catalytic reaction (26) and leads to irreversible cleavage complexes (27). Such substrates, commonly referred to as "suicide substrates," have been very useful in the study of the top1 catalytic cycle because they can be used to monitor, under single turnover conditions, the top1-mediated DNA cleavage step (28, 29).

Because top1 has been reported to bind to noncanonical DNA structures including three-stranded flaps, triple helical DNA, and Holliday junctions (30-34), we investigated the effect of G-quartets and various G-rich nucleic acids on top1 activity using purified recombinant human top1. A partially single-stranded 18-mer ODN, TH-18 (Fig. 1B), containing a high affinity site (26, 35) (Fig. 1A) was used as a "suicide substrate" (36). In this case, top1 becomes irreversibly bonded to the 3'-DNA terminus, because a pentamer oligonucleotide (28, 29) dissociates and therefore cannot be religated. This incomplete reaction leads to a "suicide complex" (Fig. 1B).

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Chemicals and Enzymes-- High pressure liquid chromatography-purified oligonucleotides were purchased from Bioserve Biotechnologies (Laurel, MD) and high pressure stopped-flow-purified oligonucleotides from MGW Biotech Inc. (High Point, NC). [alpha -32P]Cordycepin 5'-triphosphate was purchased from PerkinElmer Life Sciences. Polyacrylamide gel solutions were from National Diagnostics (Atlanta, GA). Human N-terminal truncated recombinant top1 (68 kDa) was expressed and purified essentially as reported previously (37). Briefly, the top1 gene was cloned into a baculovirus transfer vector (pBacGus-1, Novagen, Madison, WI) and used to make a recombinant baculovirus following the manufacturer's recommendations (BD-PharMingen, San Diego, CA). Top1 protein was then expressed in TN5 insect cells (HighFive, Invitrogen) by the recombinant baculovirus and purified via the N-terminal His tag essentially as described (26, 38).

Oligonucleotide Labeling and Annealing-- 3'-End-labeling was performed using terminal deoxynucleotidyl transferase (Invitrogen) with [alpha -32P]cordycepin 5'-triphosphate as described previously (39). The oligonucleotides were annealed in a buffer containing 10 mM Tris-HCl, pH 7.5, and 5 mM MgCl2 by heating for 5 min at 95 °C and cooling 30 min at 37 °C.

Intramolecular G-quartet Formation-- Intramolecular G-quartet structures were prepared as described previously (15). Briefly, oligonucleotides at 5 µM strand equivalent were heated at 90 °C for 5 min in 20 mM Li3PO4, pH 7.0 and then cooled at 4 °C for 30 min in the presence of 10 mM KCl. Intramolecular G-quartet formation was checked by thermal denaturation and circular dichroism experiments (15). Further dilutions of the intramolecular G-quartet oligonucleotides were performed in 10 mM KCl.

Intermolecular G-quartet Formation-- Intermolecular G-quartet structures were prepared as described previously (19) with the following modifications. 20 nM of 5'-end labeled single-stranded oligonucleotide was incubated for 72 h at room temperature with the same unlabeled strand (10 mM ) in a buffer containing 10 mM Tris-HCl, pH 7.5, and 1 M NaCl. Intermolecular G-quartet formation was checked by gel shift assay (19). Samples were diluted 1:10 with 10 mM Tris-HCl, pH 7.5, 10 mM KCl, and 1 mM EDTA prior to the addition of 0.5 volume of nondenaturing dye (30 mM Tris-HCl, pH 7.5, 10 mM KCl, 1 mM EDTA, 1 mg/ml bromphenol blue, and 30% glycerol). The samples were then loaded on an 8% polyacrylamide native gel (29:1) run in 0.5× TBE (100 mM Tris-HCl, pH 8.4, 90 mM boric acid, and 1 mM EDTA) and 10 mM KCl. Electrophoresis was performed at 4 °C and 5 V/cm for 3 h.

Top1 Suicide Reaction-- The suicide cleavage reactions were performed as described previously (36). Briefly, 5 pmol of recombinant top 1 were preincubated with the G-rich oligonucleotide for 5 min at room temperature in a buffer containing 10 mM Tris-HCl, pH 7.5, 50 mM KCl, 5 mM MgCl2, 0.1 mM EDTA, 15 µg/ml of bovine serum albumin, and 0.2 mM dithiothreitol. Irreversible top1-mediated DNA cleavage reaction was initiated by addition of 25 fmol of 3'-end labeled TH-18 DNA substrate in a total volume of 10 µl, and the samples were incubated for 15 min at room temperature. Reactions were stopped by adding 0.5 volume of denaturing loading dye (100% formamide, 1 mg/ml bromphenol blue, and 1 mg/ml xylene cyanol blue), and the samples were loaded on a 20% (19:1) polyacrylamide gel containing 7 M urea and 1× TBE.

CPT-induced DNA Cleavage Sites in the pSK Fragment-- A 202-bp DNA fragment was generated by PCR from the pBluescript SK(-) phagemid (Stratagene, La Jolla, CA) using the following primers: forward (514-534), 5'-GCCTCTTCGCTATTACGCCAG-3'; and reverse (693-716), 5'-GGCTGCAGGAATTCGATATCAAGC-3'. The PCR product was gel-purified using the QIAEX II Gel Purification System (Qiagen, Valencia, CA) and digested by HindIII. The resulting 177-bp DNA fragment was 3'-end labeled as described previously (40), resuspended in water, and used at ~50 nmol/reaction (50,000 dpm). Reaction conditions were identical to the ones used in the suicide reaction except for the addition of camptothecin (see above).

Top1 Binding Assay-- 10 pmol of recombinant top 1 was incubated for 30 min at room temperature with 25 fmol of 3'-end-labeled DNA substrate in a buffer containing 50 mM Tris-HCl, pH 7.5, and 50 mM NaCl in a total volume of 10 µl. The samples were treated with 0.5 volume of nondenaturing loading dye (30 mM Tris-HCl, pH 7.5, 1 mg/ml bromphenol blue, and 30% glycerol), loaded on a 6% (19:1) polyacrylamide gel containing 0.5× TBE, and electrophoresed at 4 °C, 100 V for 2 h.

Imaging and quantitation of the gels were performed using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Intramolecular G-quartets Inhibit top1-mediated DNA Cleavage-- We first studied the influence of two well characterized G-quartet-forming ODNs (T30923 and T40216) (15) on top1-mediated DNA cleavage (Fig. 2A). Both oligonucleotides inhibited top1 cleavage activity at low nanomolar concentrations (Fig. 2A). The oligonucleotide T40216 was more potent than T30923, suggesting that the length of the quartet could play a role in the inhibitory effect (Fig. 2B). T40216 was only 3 to 4 times less potent (Fig. 2B) than the high affinity full duplex substrate TH-36 (Fig. 1A), which competed with the labeled suicide substrate (final concentration 2.5 nM) and inhibited 50% of top1 cleavage (defined as IC50) at ~6 nM (Fig. 2B). These results demonstrate that top1-mediated DNA cleavage can be inhibited at low nanomolar concentrations by intramolecular G-quartet ODNs.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic representation of the suicide complex reaction. A, the TH-36 ODN corresponds to the duplex oligonucleotide containing a high affinity cleavage site for top1 (inverted black triangle). B, in the top1 suicide reaction, an 18-mer ODN (TH-18) is 3'-end-labeled by incorporation of [alpha -32P]cordycepin 5'-triphosphate in the presence of terminal transferase. The labeled product is a 19-mer ODN (including the labeled cordycepin nucleotide shown in italics and marked by an asterisk). This ODN is annealed to a 36-mer complementary strand. Top1 recognizes its high affinity site, cleaves the upper strand, and liberates a 5-mer 3'-end-labeled ODN that separates from the uncleaved strand on a denaturing gel. Top1 remains bound at the 3' extremity of the cleaved strand (suicide complex).


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2.   Inhibition of top1 cleavage by intramolecular G-quartet ODNs. A, schematic representation of the G-quartet ODNs. B, PhosphorImager representation of a typical experiment. Lanes 0, DNA plus top1. The concentrations of the G-quartet ODNs were: lanes 1, 4.5 nM; lanes 2, 13.7 nM; lanes 3, 41 nM; lanes 4, 123 nM; and lanes 5, 370 nM. C, densitometric analysis of the gel shown in B. Circles, T30923; squares, T40216; triangles, TH-36.

Intermolecular G-quartets Inhibit top1-mediated DNA Cleavage-- Because we observed that top1 can be inhibited by intramolecular G-quartets, we next investigated the effect of intermolecular G-quartet structures on top1-mediated DNA cleavage. We chose a 30-mer G-rich single-stranded oligonucleotide [ODN-1] (Fig. 3A) derived from the yeast telomeric sequence of Saccharomyces cerevisiae. This oligonucleotide can form an intermolecular parallel G-quartet (19) for which formation can be monitored by gel electrophoresis (Fig. 3B). Both single-stranded [ODN-1:SS] and quadruplex [ODN-1:G4] conformations were tested (Fig. 3C). The intermolecular G-quartet inhibited top1-mediated DNA cleavage with an IC50 of ~100 nM, which is higher than for the intramolecular G-quartets T30963 and T40216 (2- and 5-fold, respectively, compare Figs. 3B and 2B). Interestingly, ODN-1:SS was also active with an IC50 ~3 times higher than ODN-1:G4 (Fig. 3, B and C). These results demonstrate that intermolecular G-quartets can also inhibit top1-mediated DNA cleavage at a high affinity site in duplex DNA.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 3.   Inhibition of top1 cleavage by yeast telomeric sequence both as intermolecular G-quartet and as single-stranded DNA. A, sequence of the ODNs tested. B, PhosphorImager representation of the intermolecular G-quartet formation. C, PhosphorImager representation of a typical experiment. Lanes 0, DNA alone; lanes 1, DNA plus top1. The concentrations in ODN-1 were: lanes 2, 4.5 nM; lanes 3, 13.7 nM; lanes 4, 41 nM; lanes 5, 123 nM; lanes 6, 370 nM; lanes 7, 1,111 nM; lanes 8, 3,333 nM; and lanes 9, 10,000 nM. D, densitometric analysis of the gel shown in C. Circles, ODN-1:SS; squares, ODN-1:G4.

A Single-stranded 16-mer G-rich ODN Inhibits top1-mediated DNA Cleavage-- We next investigated whether a G-quartet-forming structure or a sequence containing consecutive guanosines (G-stretch) was sufficient to prevent top1 cleavage at its high affinity site. For this purpose, we designed the oligonucleotide [ODN-2], which was derived from T30923 (Fig. 4A). ODN-2 has the same base content as T30923 (12 guanines and 4 thymines) but cannot form either intra- or intermolecular G-quartets as verified by gel mobility, thermal denaturation, and circular dichroism experiments (data not shown). Nevertheless, ODN-2 inhibited top1-mediated DNA cleavage at low nanomolar concentration (Fig. 4B) and was as potent as the intramolecular G-quartets T30963 and T40216 (see Fig. 2). ODN-2 was ~6-fold more efficient than its duplex homologue, [ODN-2d], and was markedly more potent than its C-rich complementary strand, [ODN-2c] (by at least 2 orders of magnitude) (Fig. 4B). ODN-2 was also ~50-fold more potent than a non-G-rich single-stranded DNA of the same length, corresponding to the last 16 bases of HIV-1 U5 long terminal repeat sequence [ODN-3]. These results demonstrate that the single-stranded G-rich oligonucleotide ODN-2 effectively inhibits DNA cleavage.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Inhibition of top1 cleavage by a G-rich single-stranded ODN. A, sequences of the ODNs tested. B, densitometric analysis of a typical PhosphorImager picture (not shown). Circles, ODN-2; triangles, ODN-2d; squares, ODN-3; inverted triangles, ODN-2c.

DNA Sequence Specificity of G-rich Single-stranded ODNs-- To further investigate the influence of the guanine distribution in single-stranded oligonucleotides, different G-rich sequences were tested (Fig. 5A). In the oligonucleotide ODN-5, one of the thymines was moved in order to disrupt the G-stretch present in the middle of ODN-2 (Fig. 5A). ODN-5 showed approximately the same potency as ODN-2 (Fig. 5B), indicating that the 5-mer G-stretch present in the middle of ODN-2 is not required for top1 inhibition. Consistent with this observation, we found that an oligonucleotide containing only a central stretch of guanosines flanked by one thymine, [ODN-10], only inhibited top1-mediated DNA cleavage above micromolar concentrations (Fig. 5B).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 5.   Sequence-specific inhibition of top1-mediated DNA cleavage by G-rich single-stranded ODNs. A, sequences of the ODNs tested. B, densitometric analysis of a typical PhosphorImager picture (not shown). Circles, ODN-2; diamonds, ODN-5; squares, ODN-6; crosses, ODN-7; inverted triangles, ODN-8; circled dot, ODN-9; triangles, ODN-10.

The presence and position of the thymines in ODN-2 were then investigated by placing two of the four thymines at both extremities of the sequence. ODN-6 was ~5-fold less potent than ODN-2 (Fig. 5B). This difference increased to ~15-fold when the thymines were replaced by four guanines in the poly-G ODN-7, demonstrating the importance of the thymines for activity.

To investigate whether top1 cleavage could be inhibited by 5'-TpG-3' steps, which represent high affinity sites for human top1 in duplex DNA (28, 41, 42), a 16-mer ODN with an alternating TG sequence, [ODN-8], was tested. This oligonucleotide was ~150-fold less potent than ODN-2. Weak activity was also observed for a 16-mer oligonucleotide formed by four TTGG repeats, [ODN-9]. These results demonstrate the importance of the DNA sequence of G-rich single-stranded ODNs for top1-mediated DNA cleavage inhibition.

G-quartet-forming and G-rich Single-stranded ODNs Inhibit Camptothecin-induced top1 Trapping on DNA-- We next tested the effect of G-rich ODNs on camptothecin-induced top1 trapping on DNA. We performed these experiments with the PvuII-HindIII digested pBluescript SK(-) 177-bp DNA fragment, which contains previously characterized top1 cleavage sites (40). Fig. 6 shows that both oligonucleotides T30923 and ODN-2 inhibited the camptothecin-induced DNA cleavage at all sites examined. As in the case of the TH-18 suicide substrate, ODN-2 was more potent than T30923 (Fig. 6).


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 6.   Inhibition of camptothecin-induced top1 cleavage by G-quartet and G-rich single-stranded ODNs. The 177-bp pBluescript SK(-) fragment was generated by PCR and labeled as described previously (40). Camptothecin (CPT) was used at 10 µM to block top1-mediated religation and therefore reveal top1 cleavage sites.

G-rich Single-stranded and G-quartet-forming ODNs Both Bind to top1-- Gel shift experiments were performed to determine top1 binding to the G-rich single-stranded ODN-2 and to the G-quartet forming oligonucleotides (T30923T40216). These three substrates produced a band with retarded electrophoretic mobility when incubated with purified top1 (Fig. 7A). Binding efficiencies for these oligonucleotides were lower than for TH-36.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 7.   Competitive binding of top1 to G-quartet and G-rich single-stranded ODNs. A, PhosphorImager representation of a nondenaturing gel. B, densitometric analysis of a competition experiment. Squares, TH-36; circles, ODN-2.

The G-rich Single-stranded ODN-2 Displaces top1 from Its High Affinity Substrate-- To investigate further the binding of G-rich oligonucleotides to top1, competition experiments were performed in the presence of both the high affinity duplex TH-36 and ODN-2. In these experiments, a DNA-protein complex was formed between top1 and 32P-labeled TH-36 in the presence of increasing concentrations of unlabeled ODN-2 or unlabeled TH-36 (Fig. 7B). At high concentrations of unlabeled oligonucleotide, the band corresponding to the top1-labeled TH-36 complex on the gel disappeared for both ODN-2 and TH-36. This indicates that both oligonucleotides displaced top1 from its labeled substrate (TH-36). The efficiency of strand displacement was ~10 times lower for ODN-2 than for TH-36 (Fig. 7B). Furthermore, in the experiments including both TH-36 and ODN-2, we did not observe any supershift of the top1-DNA band suggesting that top1 binds either to its duplex high affinity substrate TH-36 or to the single-stranded G-rich ODN-2 but not to both at the same time. These results demonstrate that G-rich oligonucleotides can bind competitively to top1 and prevent the enzyme from cleaving duplex DNA.

G-quartet-forming and G-rich Single-stranded ODNs Are Not top1 Substrates-- To determine whether the G-quartets and G-rich single-stranded ODNs could be substrates for top1, the G-rich ODNs were labeled and tested for top1-mediated DNA cleavage. As expected, camptothecin induced cleavage in the TH-36 ODN (see Fig. 1A for sequence). Camptothecin also enhanced cleavage in the suicide TH-18 ODN, indicating that top1-mediated DNA cleavage in this oligonucleotide is partially reversible. Using ODN-2, cleavage was not detected either in the absence or presence of camptothecin (Fig. 8). A similar result was obtained with the G-quartet ODNs T30923 and T40216 (data not shown), demonstrating that these G-rich ODNs are not cleaved by top1.


View larger version (78K):
[in this window]
[in a new window]
 
Fig. 8.   The G-rich single-stranded ODN-2 is not cleaved by top1. The 3'-end-labeled substrates are indicated at the top. Camptothecin (CPT) was used at 1 µM to reveal the top1 high affinity site (see Fig. 1).

The RNA Equivalent of ODN-2 Also Inhibits top1-mediated DNA Cleavage-- We next tested the effect of single-stranded RNA on the inhibition of top1-mediated DNA cleavage. First we designed an oligodeoxynucleotide identical to ODN-2 in which thymines were replaced by uracils (Fig. 9A). ODN-11 inhibited top1 DNA-mediated cleavage (Fig. 9B) and was ~4-fold less potent than the parental ODN-2. The RNA equivalent of ODN-11, [ORN-12] (Fig. 9A), was ~2-fold more potent than its ODN homologue (Fig. 9, B and C). Thus, top1-mediated DNA cleavage can be efficiently inhibited by single-stranded G-rich RNA.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 9.   Inhibition of top1-mediated DNA cleavage by single-stranded G-rich ORNs. A, sequence of the oligodeoxynucleotide [ODN-11] and oligoribonucleotide [ODN-12] tested. B, PhosphorImager representation of a typical experiment. Lanes 0, DNA alone; lanes 1, DNA plus top1. The concentrations of the oligonucleotides were: lanes 2, 0.45 nM; lanes 3, 1.37 nM; lanes 4, 4.1 nM; lanes 5, 12.3 nM; lanes 6, 37 nM; lanes 7, 111 nM; lanes 8, 333 nM; lanes 9, 1000 nM. C, densitometric analysis of the gel shown in B. Circles, ODN-11; squares, ORN-12.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The present study demonstrates that both intra- and intermolecular G-quartets and single-stranded G-rich ODNs inhibit top1-mediated DNA cleavage. This inhibition appears to require repeats of at least 2~3 consecutive guanines interspaced with thymines. We also demonstrate that the inhibition of top1-mediated DNA cleavage can be efficiently achieved with G-rich RNA and that the G-quartet-forming and single-stranded G-rich ODNs bind competitively to top1 without being cleaved by the enzyme.

It is becoming increasingly clear that top1 can bind to noncanonical DNA structures. DNA containing partially single-stranded regions and extra-helical segments (bulges) were shown to be cleaved by the enzyme (26, 43, 44). Top1 also cleaves DNA sites with local structure distortion including oxidative base modifications (36), base mismatches and abasic sites (45), UV photoproducts (46), base methylation (47), intercalation (48), and minor groove alkylation (49, 50). Top1 has also been found to cleave three-stranded flap regions and promote their DNA recombination (30, 31). Top1 binding to triple helical DNA has also been reported (32) as well as binding to Holliday junctions, which correspond to four-stranded structures as in the case of G-quartets (33, 34). However in contrast to the Holliday junctions, the G-quartets we examined are not cleaved by top1. More recently, Hélène and co-workers (51) also reported that top1 binds to preformed inter- and intramolecular G-quartets and promotes the opening of a 69-bp duplex to form a stable intermolecular G-quartet-containing structure. It is therefore intriguing how top1 can bind to such diverse structures. Recently the structure of top1 bound covalently and noncovalently to duplex DNA has been determined, and the enzyme has been shown to encircle the DNA duplex (52, 53). The finding that top1 can also bind to G-rich single-stranded and four-stranded DNA suggests that the enzyme can accommodate various size nucleic acids.

High affinity binding of top1 to single-stranded DNA or RNA has not been reported previously. In fact, binding to nonspecific single-stranded DNA with random sequence was weak (54) and was detectable only in segments that had the potential to form duplex structures (55). Top1 is known to play an important role in transcription (for review see Ref. 56) by direct binding to transcription complexes (57-60) and phosphorylation of serine-arginine rich (SR) splicing factors that control pre-mRNA splicing (61). Top1 enhances TFIID-TFIIA complex assembly during activation of transcription (62) and interacts with TFIIIC to promote accurate termination and reinitiation (63). In this work, we report top1 inhibition by G-rich-containing RNA oligonucleotides. The in vivo significance of top1 binding to T- and G-rich single-stranded RNA still remains to be determined, but it is possible that top1 could play a role in the stabilization of such sequences during transcription, preventing their folding into higher order structures. Top1 binding to T- and G-rich single-stranded RNA might contribute to the activity of the enzyme in RNA splicing (64, 65). These results point to top1 being a multifunctional enzyme capable of accommodating varied DNA structures.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Laboratory of Molecular Pharmacology, Center for Cancer Research, Bldg. 37, Rm. 5068, NCI, National Institutes of Health, Bethesda, MD 20892-4255. Tel.: 301-496-5944; Fax: 301-402-0752; E-mail: pommier@nih.gov.

Published, JBC Papers in Press, December 26, 2001, DOI 10.1074/jbc.M106372200

    ABBREVIATIONS

The abbreviations used are: top1, topoisomerase I; ODN, oligodeoxynucleotide; ORN, oligoribonucleotide; TF, transcription factor.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Han, H. Y., and Hurley, L. H. (2000) Trends Pharmacol. Sci. 21, 136-142[CrossRef][Medline] [Order article via Infotrieve]
2. Blackburn, E. H., and Szostak, J. W. (1984) Annu. Rev. Biochem. 53, 163-194[CrossRef][Medline] [Order article via Infotrieve]
3. Evans, T., Schon, E., Goramaslak, G., Patterson, J., and Efstratiadis, A. (1984) Nucleic Acids Res. 12, 8043-8058[Abstract/Free Full Text]
4. Kilpatrick, M. W., Torri, A., Kang, D. S., Engler, J. A., and Wells, R. D. (1986) J. Biol. Chem. 261, 1350-1354
5. Shimizu, A., and Honjo, T. (1984) Cell 36, 801-803[CrossRef][Medline] [Order article via Infotrieve]
6. Sen, D., and Gilbert, W. (1988) Nature 334, 364-366[CrossRef][Medline] [Order article via Infotrieve]
7. Sundquist, W. I., and Klug, A. (1989) Nature 342, 825-829[CrossRef][Medline] [Order article via Infotrieve]
8. Williamson, J. R., Raghuraman, M. K., and Cech, T. R. (1989) Cell 59, 871-880[CrossRef][Medline] [Order article via Infotrieve]
9. Fang, G. W., and Cech, T. R. (1993) Cell 74, 875-885[CrossRef][Medline] [Order article via Infotrieve]
10. Weismanshomer, P., and Fry, M. (1993) J. Biol. Chem. 268, 3306-3312[Abstract/Free Full Text]
11. Giraldo, R., and Rhodes, D. (1994) EMBO J. 13, 2411-2420[Medline] [Order article via Infotrieve]
12. Erlitzki, R., and Fry, M. (1997) J. Biol. Chem. 272, 15881-15890[Abstract/Free Full Text]
13. Sarig, G., Weisman-Shomer, P., Erlitzki, R., and Fry, M. (1997) J. Biol. Chem. 272, 4474-4482[Abstract/Free Full Text]
14. Dempsey, L. A., Sun, H., Hanakahi, L. A., and Maizels, N. (1999) J. Biol. Chem. 274, 1066-1071[Abstract/Free Full Text]
15. Jing, N. J., Marchand, C., Liu, J., Mitra, R., Hogan, M. E., and Pommier, Y. (2000) J. Biol. Chem. 275, 21460-21467[Abstract/Free Full Text]
16. Giraldo, R., Suzuki, M., Chapman, L., and Rhodes, D. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 7658-7662[Abstract/Free Full Text]
17. Baran, N., Pucshansky, L., Marco, Y., Benjamin, S., and Manor, H. (1997) Nucleic Acids Res. 25, 297-303[Abstract/Free Full Text]
18. Sun, H., Karow, J. K., Hickson, I. D., and Maizels, N. (1998) J. Biol. Chem. 273, 27587-27592[Abstract/Free Full Text]
19. Sun, H., Bennett, R. J., and Maizels, N. (1999) Nucleic Acids Res. 27, 1978-1984[Abstract/Free Full Text]
20. Fry, M., and Loeb, L. A. (1999) J. Biol. Chem. 274, 12797-12802[Abstract/Free Full Text]
21. Gupta, M., Fujimori, A., and Pommier, Y. (1995) Biochim. Biophys. Acta 1262, 1-14[Medline] [Order article via Infotrieve]
22. Wang, J. C. (1996) Annu. Rev. Biochem. 65, 635-692[CrossRef][Medline] [Order article via Infotrieve]
23. Champoux, J. J. (1981) J. Biol. Chem. 256, 4805-4809[Abstract/Free Full Text]
24. Chen, A. Y., and Liu, L. F. (1994) Annu. Rev. Pharmacol. Toxicol. 94, 194-218
25. Pommier, Y. (1996) Semin. Oncol. 23, 1-10[Medline] [Order article via Infotrieve]
26. Pourquier, P., Pilon, A. A., Kohlhagen, G., Mazumder, A., Sharma, A., and Pommier, Y. (1997) J. Biol. Chem. 272, 26441-26447[Abstract/Free Full Text]
27. Pourquier, P., and Pommier, Y. (2001) Adv. Cancer Res. 80, 189-216[Medline] [Order article via Infotrieve]
28. Svejstrup, J. Q., Christiansen, K., Gromova, I. I., Andersen, A. H., and Westergaard, O. (1991) J. Mol. Biol. 222, 669-678[CrossRef][Medline] [Order article via Infotrieve]
29. Shuman, S. (1991) J. Biol. Chem. 266, 1796-1803[Abstract/Free Full Text]
30. Pourquier, P., Jensen, A. D., Gong, S. S., Pommier, Y., and Rogler, C. E. (1999) Nucleic Acids Res. 27, 1919-1925[Abstract/Free Full Text]
31. Cheng, C. H., and Shuman, S. (2000) Mol. Cell. Biol. 20, 8059-8068[Abstract/Free Full Text]
32. Arimondo, P. B., Moreau, P., Boutorine, A., Bailly, C., Prudhomme, M., Sun, J. S., Garestier, T., and Hélène, C. (2000) Bioorg. Med. Chem. 8, 777-784[CrossRef][Medline] [Order article via Infotrieve]
33. Sekiguchi, J., Seeman, N. C., and Shuman, S. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 785-789[Abstract/Free Full Text]
34. Sekiguchi, J., Cheng, C. H., and Shuman, S. (2000) Nucleic Acids Res. 28, 2658-2663[Abstract/Free Full Text]
35. Bonven, B. J., Gocke, E., and Westergaard, O. (1985) Cell 41, 541-551[CrossRef][Medline] [Order article via Infotrieve]
36. Pourquier, P., Ueng, L. M., Fertala, J., Wang, D., Park, H. J., Essigmann, J. M., Bjornsti, M. A., and Pommier, Y. (1999) J. Biol. Chem. 274, 8516-8523[Abstract/Free Full Text]
37. Pourquier, P., Takebayashi, Y., Urasaki, Y., Gioffre, C., Kohlhagen, G., and Pommier, Y. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 1885-1890[Abstract/Free Full Text]
38. Zhelkovsky, A. M., Moore, C. L., Rattner, J. B., Hendzel, M. J., Furbee, C. S., Muller, M. T., and Bazett-Jones, D. P. (1994) Protein Expression Purif. 5, 364-370[CrossRef][Medline] [Order article via Infotrieve]
39. Pommier, Y., Jenkins, J., Kohlhagen, G., and Leteurtre, F. (1995) Mutat. Res. 337, 135-145[CrossRef][Medline] [Order article via Infotrieve]
40. Cushman, M., Jayaraman, M., Vroman, J. A., Fukunaga, A. K., Fox, B. M., Kohlhagen, G., Strumberg, D., and Pommier, Y. (2000) J. Med. Chem. 43, 3688-3698[CrossRef][Medline] [Order article via Infotrieve]
41. Been, M. D., Burgess, R. R., and Champoux, J. J. (1984) Nucleic Acids Res. 12, 3097-3114[Abstract/Free Full Text]
42. Porter, S. E., and Champoux, J. J. (1989) Mol. Cell. Biol. 9, 541-550[Abstract/Free Full Text]
43. Henningfeld, K. A., and Hecht, S. (1995) Biochemistry 34, 6120-6129[CrossRef][Medline] [Order article via Infotrieve]
44. Wang, X., Henningfeld, K. A., and Hecht, S. M. (1998) Biochemistry 37, 2691-2700[CrossRef][Medline] [Order article via Infotrieve]
45. Pourquier, P., Ueng, L. M., Kohlhagen, G., Mazumder, A., Gupta, M., Kohn, K. W., and Pommier, Y. (1997) J. Biol. Chem. 272, 7792-7796[Abstract/Free Full Text]
46. Lanza, A., Tornatelli, S., Rodolfo, C., Scanavini, M. C., and Pedrini, A. M. (1996) J. Biol. Chem. 271, 6978-6986[Abstract/Free Full Text]
47. Leteurtre, F., Kohlhagen, G., Fesen, M. R., Tanizawa, A., Kohn, K. W., and Pommier, Y. (1994) J. Biol. Chem. 269, 7893-7900[Abstract/Free Full Text]
48. Pommier, Y., Laco, G. S., Kohlhagen, G., Sayer, J. M., Kroth, H., and Jerina, D. M. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 10739-10744[Abstract/Free Full Text]
49. Takebayashi, Y., Pourquier, P., Yoshida, A., Kohlhagen, G., and Pommier, Y. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 7196-7201[Abstract/Free Full Text]
50. Pommier, Y., Kohlhagen, G., Pourquier, P., Sayer, J. M., Kroth, H., and Jerina, D. M. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 2040-2045[Abstract/Free Full Text]
51. Arimondo, P. B., Riou, J. F., Mergny, J. L., Tazi, J., Sun, J. S., Garestier, T., and Hélène, C. (2000) Nucleic Acids Res. 28, 4832-4838[Abstract/Free Full Text]
52. Redinbo, M. R., Stewart, L., Kuhn, P., Champoux, J. J., and Hol, W. G. J. (1998) Science 279, 1504-1513[Abstract/Free Full Text]
53. Redinbo, M. R., Champoux, J. J., and Hol, W. G. J. (2000) Biochemistry 39, 6832-6840[CrossRef][Medline] [Order article via Infotrieve]
54. Jaxel, C., Capranico, G., Kerrigan, D., Kohn, K. W., and Pommier, Y. (1991) J. Biol. Chem. 266, 20418-20423[Abstract/Free Full Text]
55. Been, M. D., and Champoux, J. J. (1984) J. Mol. Biol. 180, 515-531[CrossRef][Medline] [Order article via Infotrieve]
56. Tazi, J., Rossi, F., Labourier, E., Gallouzi, I., Brunel, C., and Antoine, E. (1997) J. Mol. Med. 75, 786-800[CrossRef][Medline] [Order article via Infotrieve]
57. Merino, A., Madden, K. R., Lane, W. S., Champoux, J. J., and Reinberg, D. (1993) Nature 365, 227-232[CrossRef][Medline] [Order article via Infotrieve]
58. Kretzschmar, M., Meisterernst, M., and Roeder, R. G. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11508-11512[Abstract/Free Full Text]
59. Straub, T., Grue, P., Uhse, A., Lisby, M., Knudsen, B. R., Tange, T. O., Westergaard, O., and Boege, F. (1998) J. Biol. Chem. 273, 26261-26264[Abstract/Free Full Text]
60. Edwards, T. K., Saleem, A., Shaman, J. A., Dennis, T., Gerigk, C., Oliveros, E., Gartenberg, M. R., and Rubin, E. H. (2000) J. Biol. Chem. 275, 36181-36188[Abstract/Free Full Text]
61. Rossi, F., Labourier, E., Forne, T., Divita, G., Derancourt, J., Riou, J. F., Antoine, E., Cathala, G., Brunel, C., and Tazi, J. (1996) Nature 381, 80-82[CrossRef][Medline] [Order article via Infotrieve]
62. Shykind, B. M., Kim, J., Stewart, L., Champoux, J. J., and Sharp, P. A. (1997) Genes Dev. 11, 397-407[Abstract/Free Full Text]
63. Wang, Z. X., and Roeder, R. G. (1998) Mol. Cell. 1, 749-757[CrossRef][Medline] [Order article via Infotrieve]
64. Rossi, F., Labourier, E., Gallouzi, I. E., Derancourt, J., Allemand, E., Divita, G., and Tazi, J. (1998) Nucleic Acids Res. 26, 2963-2970[Abstract/Free Full Text]
65. Labourier, E., Rossi, F., Gallouzi, I. E., Allemand, E., Divita, G., and Tazi, J. (1998) Nucleic Acids Res. 26, 2955-2962[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
N. Jing, Q. Zhu, P. Yuan, Y. Li, L. Mao, and D. J. Tweardy
Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer.
Mol. Cancer Ther., February 1, 2006; 5(2): 279 - 286.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Antony, P. B. Arimondo, J.-S. Sun, and Y. Pommier
Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures
Nucleic Acids Res., October 4, 2004; 32(17): 5163 - 5173.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Jing, Y. Li, W. Xiong, W. Sha, L. Jing, and D. J. Tweardy
G-Quartet Oligonucleotides: A New Class of Signal Transducer and Activator of Transcription 3 Inhibitors That Suppresses Growth of Prostate and Breast Tumors through Induction of Apoptosis
Cancer Res., September 15, 2004; 64(18): 6603 - 6609.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/11/8906    most recent
M106372200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marchand, C.
Right arrow Articles by Pommier, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchand, C.
Right arrow Articles by Pommier, Y.
Social Bookmarking